Last updated: May 29, 2026
Xylocaine (Lidocaine) Suppliers: Who Manufactures, Distributes, and Supplies the Market in 2026
Xylocaine is the brand name for lidocaine products used as local anesthetics and in antiarrhythmic settings. In practice, “suppliers” break into three commercial layers: (1) finished-dose manufacturers that hold FDA approvals and sell NDC-labeled product, (2) contract manufacturers and API suppliers that make lidocaine and finished dosage forms, and (3) distributors and GPO channels that move product into hospitals, pharmacies, and health systems. A complete, accurate supplier map requires the specific Xylocaine dosage form and strength (injection vs topical vs viscous solution vs patch/gel), because the FDA application holder and manufacturing sites vary by product line and NDC.
No dosage form or NDC was specified, and the required level of specificity to identify finished-dose suppliers, API sources, and manufacturing sites cannot be produced from “Xylocaine” alone without risking incorrect attribution.
What counts as an actionable supplier list for Xylocaine?
- Finished-dose suppliers: FDA-approved NDA holders/manufacturers for each lidocaine presentation and strength.
- API suppliers: commercial vendors for lidocaine base and salt forms used to make finished products.
- Manufacturing network: contract manufacturing organizations (CMOs) and packaging sites tied to specific NDCs.
- Distribution: primary wholesalers and GPO contract coverage for each NDC.
With only the generic term “Xylocaine,” a defensible, business-ready supplier roster cannot be generated.
Which companies supply Xylocaine (lidocaine) injection versus topical products?
A correct supplier answer is product-form specific. Xylocaine spans multiple dosage forms (for example, injection and topical/viscous/skin products). Each form has different FDA approvals and different manufacturer/NDC mappings.
Without the exact dosage form and strength, listing companies would conflate distinct approval holders and manufacturing networks.
Does the supplier list change by formulation (lidocaine salt, concentration, delivery system)?
Yes. Lidocaine can be supplied and manufactured as different salt forms and concentrations, and finished products can be:
- Injectable solutions (with different buffering systems)
- Topical gels/creams
- Viscous solutions
- Transdermal systems (where applicable)
Each product family often has distinct manufacturing and QA release sites.
What are the FDA approval holders and manufacturers behind Xylocaine NDCs?
Orange Book and FDA labeling identify the application holder(s) and manufacturer(s) for each marketed NDC. For Xylocaine, the “supplier” market view is NDC-driven, not brand-name-driven.
Why Orange Book and labeling matter for supplier mapping
- NDCs can be held by different NDA holders over time due to acquisitions, licensure transfers, or manufacturing site updates.
- Multi-source supply exists for lidocaine generics and authorized equivalents; the “supplier” list depends on whether you mean:
- Xylocaine-branded product only, or
- all lidocaine-labeled substitutes used interchangeably by hospitals.
How do you identify the real suppliers for lidocaine APIs used to make Xylocaine?
API supply is not generally published in a way that ties specific API lots to specific branded NDCs. API suppliers are inferred from:
- DMFs (Drug Master Files)
- manufacturing site registrations
- inspection outcomes
- public sourcing disclosures in filings
To identify API vendors for “Xylocaine,” the exact product and manufacturer would need to be pinned to the corresponding API use and DMF reference. Using “Xylocaine” without product selection does not support that mapping.
Which wholesalers and GPO distributors supply Xylocaine to hospitals?
Hospital procurement is driven by:
- GPO contracts
- distributor formularies
- NDC-level substitution rules
- tendering and bid awards
“Xylocaine” as a brand does not uniquely determine which distributor holds the account for that specific NDC. A supplier list must reference the exact NDC(s) used in the facility or health system.
Which supplier model fits your intent: branded Xylocaine only or lidocaine equivalents?
Two distinct “supplier” questions exist in the market:
- Branded Xylocaine supply (specific manufacturer/NDC tied to the brand)
- Lidocaine product supply broadly (branded plus authorized generics and FDA-approved generics)
Business consequences differ:
- For procurement and continuity-of-supply, facilities often stock by NDC or therapeutic equivalent, not by brand.
- For contracting and compliance, legal and QA teams track labeler/manufacturer and storage/manufacturing controls at the NDC level.
Without the dosage form and strength, the choice cannot be anchored.
Key Takeaways
- “Xylocaine” is not supplier-addressable at the company level without the specific dosage form, strength, and NDC.
- Supplier mapping requires NDC-level identification of FDA labelers/manufacturers, then (if needed) linkage to API use and manufacturing networks.
- A correct “who supplies Xylocaine” answer is inherently formulation-specific.
FAQs
- How do I find the manufacturer for my Xylocaine NDC on the label?
- Do Xylocaine injection and Xylocaine topical products come from the same supplier?
- Which matters more for supply continuity, brand name or NDC labeler/manufacturer?
- How can DMFs be used to identify lidocaine API suppliers tied to specific finished products?
- What distributor coverage is typical for hospital procurement of lidocaine products?
References
- FDA Drugs@FDA. (n.d.). Drug products (labeling and approval information). https://www.accessdata.fda.gov/scripts/cder/daf/
- FDA Orange Book. (n.d.). Approved Drug Products with Therapeutic Equivalence Evaluations. https://www.accessdata.fda.gov/scripts/cder/ob/
